TWI716446B - 橋聯哌啶衍生物 - Google Patents
橋聯哌啶衍生物 Download PDFInfo
- Publication number
- TWI716446B TWI716446B TW105129076A TW105129076A TWI716446B TW I716446 B TWI716446 B TW I716446B TW 105129076 A TW105129076 A TW 105129076A TW 105129076 A TW105129076 A TW 105129076A TW I716446 B TWI716446 B TW I716446B
- Authority
- TW
- Taiwan
- Prior art keywords
- triazolo
- amine
- azabicyclo
- tetrahydro
- trifluoromethyl
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 324
- 239000000203 mixture Substances 0.000 claims abstract description 91
- 150000003839 salts Chemical class 0.000 claims abstract description 35
- 239000002253 acid Substances 0.000 claims abstract description 28
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 22
- 230000003287 optical effect Effects 0.000 claims abstract description 21
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 16
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 208000024667 ABeta amyloidosis, Dutch type Diseases 0.000 claims abstract description 8
- 201000010374 Down Syndrome Diseases 0.000 claims abstract description 7
- 208000017004 dementia pugilistica Diseases 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 159
- -1 (Methyl)phenyl Chemical group 0.000 claims description 151
- 229910052736 halogen Inorganic materials 0.000 claims description 129
- 150000002367 halogens Chemical class 0.000 claims description 129
- 125000000217 alkyl group Chemical group 0.000 claims description 77
- 239000001257 hydrogen Substances 0.000 claims description 66
- 229910052739 hydrogen Inorganic materials 0.000 claims description 66
- 229910052740 iodine Inorganic materials 0.000 claims description 52
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 51
- 125000003545 alkoxy group Chemical group 0.000 claims description 51
- 239000011630 iodine Substances 0.000 claims description 51
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 claims description 49
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 44
- 229910052799 carbon Inorganic materials 0.000 claims description 35
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 32
- 150000002431 hydrogen Chemical class 0.000 claims description 29
- QGCRJRVFQZXCAZ-UHFFFAOYSA-N 1h-triazolo[1,5-a]pyridin-2-amine Chemical compound C1=CC=CC2=CN(N)NN21 QGCRJRVFQZXCAZ-UHFFFAOYSA-N 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 150000001335 aliphatic alkanes Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- 206010008111 Cerebral haemorrhage Diseases 0.000 claims description 6
- 206010012289 Dementia Diseases 0.000 claims description 6
- 208000036536 dutch type ABeta amyloidosis Diseases 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 206010016202 Familial Amyloidosis Diseases 0.000 claims description 5
- 206010061216 Infarction Diseases 0.000 claims description 5
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims description 5
- 208000017105 hereditary amyloidosis Diseases 0.000 claims description 5
- 230000007574 infarction Effects 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims 4
- 230000002490 cerebral effect Effects 0.000 claims 3
- 208000019553 vascular disease Diseases 0.000 claims 3
- 150000007513 acids Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 208000005145 Cerebral amyloid angiopathy Diseases 0.000 abstract description 4
- 208000005314 Multi-Infarct Dementia Diseases 0.000 abstract description 2
- 201000004810 Vascular dementia Diseases 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 546
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 396
- 239000002585 base Substances 0.000 description 374
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 282
- 239000011541 reaction mixture Substances 0.000 description 211
- 238000004587 chromatography analysis Methods 0.000 description 194
- 239000007787 solid Substances 0.000 description 187
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 139
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 126
- 239000000741 silica gel Substances 0.000 description 120
- 229910002027 silica gel Inorganic materials 0.000 description 120
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 108
- 239000000243 solution Substances 0.000 description 107
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 79
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 64
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 60
- 239000011737 fluorine Substances 0.000 description 59
- 229910052731 fluorine Inorganic materials 0.000 description 59
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 56
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 55
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 47
- 238000006243 chemical reaction Methods 0.000 description 46
- 238000003756 stirring Methods 0.000 description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 42
- 239000011777 magnesium Substances 0.000 description 41
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 40
- 229910052749 magnesium Inorganic materials 0.000 description 40
- 239000000725 suspension Substances 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 38
- 241000208340 Araliaceae Species 0.000 description 34
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 34
- 235000003140 Panax quinquefolius Nutrition 0.000 description 34
- 235000008434 ginseng Nutrition 0.000 description 34
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 32
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 32
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 32
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 30
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 30
- 239000012414 tert-butyl nitrite Substances 0.000 description 30
- JCUYKJIVFPLSFL-UHFFFAOYSA-N P.C1=CC=CC=2OC3=CC=CC=C3CC12 Chemical compound P.C1=CC=CC=2OC3=CC=CC=C3CC12 JCUYKJIVFPLSFL-UHFFFAOYSA-N 0.000 description 27
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- 239000011521 glass Substances 0.000 description 26
- IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 235000017557 sodium bicarbonate Nutrition 0.000 description 23
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 23
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 22
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 21
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 20
- 229910000024 caesium carbonate Inorganic materials 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical group CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 20
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 20
- 235000019253 formic acid Nutrition 0.000 description 19
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 18
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- 239000012044 organic layer Substances 0.000 description 17
- RJPVRJUUZMRZSB-UHFFFAOYSA-N 8-amino-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound NC1C2CCC1CN(C2)C(O)=O RJPVRJUUZMRZSB-UHFFFAOYSA-N 0.000 description 16
- 229920006395 saturated elastomer Polymers 0.000 description 16
- SUFKKFLJJMKVJJ-UHFFFAOYSA-N 8-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound BrC1=CC=CN2N=C(N)N=C21 SUFKKFLJJMKVJJ-UHFFFAOYSA-N 0.000 description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 14
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 12
- 229910000062 azane Inorganic materials 0.000 description 12
- 239000000460 chlorine Substances 0.000 description 12
- 229910052801 chlorine Inorganic materials 0.000 description 12
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- 229910052794 bromium Inorganic materials 0.000 description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 10
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 10
- AEXITZJSLGALNH-UHFFFAOYSA-N n'-hydroxyethanimidamide Chemical compound CC(N)=NO AEXITZJSLGALNH-UHFFFAOYSA-N 0.000 description 10
- 235000005074 zinc chloride Nutrition 0.000 description 10
- 239000011592 zinc chloride Substances 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- KLFIDXBWKMWDOF-UHFFFAOYSA-N 2-bromo-5-methyl-1,3,4-oxadiazole Chemical compound CC1=NN=C(Br)O1 KLFIDXBWKMWDOF-UHFFFAOYSA-N 0.000 description 8
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 8
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 8
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 8
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 7
- 108010064539 amyloid beta-protein (1-42) Proteins 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000001665 trituration Methods 0.000 description 7
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 6
- 239000012298 atmosphere Substances 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000006260 foam Substances 0.000 description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- YSRCXLROFNRHLU-UHFFFAOYSA-N 2-hydroxyethanimidamide Chemical compound NC(=N)CO YSRCXLROFNRHLU-UHFFFAOYSA-N 0.000 description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- HRCKNYWKHBWFJH-UHFFFAOYSA-N 8-bromo-5-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(=N1)C(Br)=CC=C2C(F)(F)F HRCKNYWKHBWFJH-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 108010050254 Presenilins Proteins 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 4
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 239000007937 lozenge Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 238000002953 preparative HPLC Methods 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000012312 sodium hydride Substances 0.000 description 4
- 229910000104 sodium hydride Inorganic materials 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- DVXZEFKKDMRSFS-UHFFFAOYSA-N 2-bromo-8-[2-fluoro-4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(C=CC(=C1)C(F)(F)F)C1=CC=CN2N=C(Br)N=C12 DVXZEFKKDMRSFS-UHFFFAOYSA-N 0.000 description 3
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 125000006847 BOC protecting group Chemical group 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- 238000007125 Buchwald synthesis reaction Methods 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000015499 Presenilins Human genes 0.000 description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 description 3
- JNSBEPKGFVENFS-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC=C1C(F)(F)F JNSBEPKGFVENFS-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000006798 ring closing metathesis reaction Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 2
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 2
- AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 2
- HJNHUFQGDJLQRS-UHFFFAOYSA-N 2-(3-bromopropoxy)oxane Chemical compound BrCCCOC1CCCCO1 HJNHUFQGDJLQRS-UHFFFAOYSA-N 0.000 description 2
- NODZIZVWOCSKRF-UHFFFAOYSA-N 2-bromo-8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(F)C(F)=CC=C1C1=CC=CN2C1=NC(Br)=N2 NODZIZVWOCSKRF-UHFFFAOYSA-N 0.000 description 2
- PNTYGOBZCMESJG-UHFFFAOYSA-N 3-bromo-6-(trifluoromethyl)pyridin-2-amine Chemical compound NC1=NC(C(F)(F)F)=CC=C1Br PNTYGOBZCMESJG-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- RXSFWOTURLPILL-UHFFFAOYSA-N 5-(trifluoromethyl)-8-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(=N1)C(=CC=C2C(F)(F)F)C1=C(C=CC=C1)C(F)(F)F RXSFWOTURLPILL-UHFFFAOYSA-N 0.000 description 2
- QVOMODJYHGQJEB-UHFFFAOYSA-N 5-(trifluoromethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(=N1)C(=CC=C2C(F)(F)F)C1=CC(=CC=C1)C(F)(F)F QVOMODJYHGQJEB-UHFFFAOYSA-N 0.000 description 2
- SVRANALJROBNNY-UHFFFAOYSA-N 5-(trifluoromethyl)-8-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(=N1)C(=CC=C2C(F)(F)F)C1=CC=C(C=C1)C(F)(F)F SVRANALJROBNNY-UHFFFAOYSA-N 0.000 description 2
- OOKDHUXRTQLTHM-UHFFFAOYSA-N 6-(trifluoromethyl)-8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=C(C=C(C2=N1)C1=C(F)C(F)=C(F)C=C1)C(F)(F)F OOKDHUXRTQLTHM-UHFFFAOYSA-N 0.000 description 2
- QLHCKTZQYDAPMI-UHFFFAOYSA-N 8-(3,4,5-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC(F)=C(F)C(F)=C1 QLHCKTZQYDAPMI-UHFFFAOYSA-N 0.000 description 2
- NIRXAMVVUNETES-UHFFFAOYSA-N 8-[2-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=C(OC(F)(F)F)C=CC=C1 NIRXAMVVUNETES-UHFFFAOYSA-N 0.000 description 2
- NEGNZLNFAOOJMD-UHFFFAOYSA-N 8-[2-methoxy-4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound COC1=C(C=CC(=C1)C(F)(F)F)C1=CC=CN2N=C(N)N=C12 NEGNZLNFAOOJMD-UHFFFAOYSA-N 0.000 description 2
- OHYYXWNFJYCNPH-UHFFFAOYSA-N 8-[3-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC(OC(F)(F)F)=CC=C1 OHYYXWNFJYCNPH-UHFFFAOYSA-N 0.000 description 2
- WHEIAUYWSGXVDT-UHFFFAOYSA-N 8-[4-(2,2,2-trifluoroethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(OCC(F)(F)F)C=C1 WHEIAUYWSGXVDT-UHFFFAOYSA-N 0.000 description 2
- VDEPVJMSHXIXGL-UHFFFAOYSA-N 8-[4-(difluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(OC(F)F)C=C1 VDEPVJMSHXIXGL-UHFFFAOYSA-N 0.000 description 2
- QLNKHFLZPXGSGM-UHFFFAOYSA-N 8-[4-(difluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(C=C1)C(F)F QLNKHFLZPXGSGM-UHFFFAOYSA-N 0.000 description 2
- YEEFYXUPQRERMI-UHFFFAOYSA-N 8-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(OC(F)(F)F)C=C1 YEEFYXUPQRERMI-UHFFFAOYSA-N 0.000 description 2
- XSJYFFPGZYRVBV-UHFFFAOYSA-N 8-[4-(trifluoromethylsulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(SC(F)(F)F)C=C1 XSJYFFPGZYRVBV-UHFFFAOYSA-N 0.000 description 2
- WYMZXLOITHKGTF-UHFFFAOYSA-N 8-bromo-2-chloro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound BrC1=CC=CN2N=C(Cl)N=C21 WYMZXLOITHKGTF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- VHIBOFWCGOAFJE-UHFFFAOYSA-N C1=CC=C[C-]1P(C1=CC=CC=C1)C1=CC=CC=C1.C1=CC=C[C-]1P(C1=CC=CC=C1)C1=CC=CC=C1.Cl.Cl.[Fe+2] Chemical compound C1=CC=C[C-]1P(C1=CC=CC=C1)C1=CC=CC=C1.C1=CC=C[C-]1P(C1=CC=CC=C1)C1=CC=CC=C1.Cl.Cl.[Fe+2] VHIBOFWCGOAFJE-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 2
- 108010070047 Notch Receptors Proteins 0.000 description 2
- 102000005650 Notch Receptors Human genes 0.000 description 2
- MXFNQOUDSLSAEC-UHFFFAOYSA-N OC(N(CC1CC2)CC2C1NC1=NN(CCCC2C(C=CC(C(F)(F)F)=C3)=C3F)C2=N1)=O Chemical compound OC(N(CC1CC2)CC2C1NC1=NN(CCCC2C(C=CC(C(F)(F)F)=C3)=C3F)C2=N1)=O MXFNQOUDSLSAEC-UHFFFAOYSA-N 0.000 description 2
- 101000579647 Penaeus vannamei Penaeidin-2a Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 2
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 150000001543 aryl boronic acids Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000013058 crude material Substances 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- 239000003365 glass fiber Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- ZVYXEXAXXWINEH-UHFFFAOYSA-N n,n-diethyl-2-hydroxybenzamide Chemical compound CCN(CC)C(=O)C1=CC=CC=C1O ZVYXEXAXXWINEH-UHFFFAOYSA-N 0.000 description 2
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 229940049953 phenylacetate Drugs 0.000 description 2
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- CXVOFJWDXNAZRW-UHFFFAOYSA-N tert-butylhydrazine formic acid Chemical compound C(=O)O.C(C)(C)(C)NN CXVOFJWDXNAZRW-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- AQWOIRBQLOOZGX-UHFFFAOYSA-N triazolo[1,5-a]pyridine Chemical group C1=CC=CC2=CN=NN21 AQWOIRBQLOOZGX-UHFFFAOYSA-N 0.000 description 2
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 2
- 235000019798 tripotassium phosphate Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 2
- JWZGJDATMFMKIO-UHFFFAOYSA-N (2,3,4-trifluorophenoxy)boronic acid Chemical compound OB(O)OC1=CC=C(F)C(F)=C1F JWZGJDATMFMKIO-UHFFFAOYSA-N 0.000 description 1
- CLGIPVVEERQWSQ-UHFFFAOYSA-N (2,3,4-trifluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1F CLGIPVVEERQWSQ-UHFFFAOYSA-N 0.000 description 1
- 150000005071 1,2,4-oxadiazoles Chemical class 0.000 description 1
- PVBVOTISXJPMFC-UHFFFAOYSA-N 1-bromo-4-(1,1,2,2,2-pentafluoroethyl)benzene Chemical compound FC(F)(F)C(F)(F)C1=CC=C(Br)C=C1 PVBVOTISXJPMFC-UHFFFAOYSA-N 0.000 description 1
- SFOYQZYQTQDRIY-UHFFFAOYSA-N 1-chloro-3-iodopropane Chemical compound ClCCCI SFOYQZYQTQDRIY-UHFFFAOYSA-N 0.000 description 1
- ZSDQQJHSRVEGTJ-UHFFFAOYSA-N 2-(6-amino-1h-indol-3-yl)acetonitrile Chemical compound NC1=CC=C2C(CC#N)=CNC2=C1 ZSDQQJHSRVEGTJ-UHFFFAOYSA-N 0.000 description 1
- WFHUJSXDNKENRM-UHFFFAOYSA-N 2-bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1CCCN2N=C(Br)N=C21 WFHUJSXDNKENRM-UHFFFAOYSA-N 0.000 description 1
- DEKUFIWJEXORDC-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-8-(2,3,4-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(F)C(F)=C(C=C1)C1CCC(N2N=C(Br)N=C12)C(F)(F)F DEKUFIWJEXORDC-UHFFFAOYSA-N 0.000 description 1
- YBVAQTNKHKXEDP-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-8-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=C(C2=NC(Br)=NN12)C1=C(C=CC=C1)C(F)(F)F YBVAQTNKHKXEDP-UHFFFAOYSA-N 0.000 description 1
- BZQPRLHFNMNKDK-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=CC(=C1)C1=CC=C(N2N=C(Br)N=C12)C(F)(F)F BZQPRLHFNMNKDK-UHFFFAOYSA-N 0.000 description 1
- TWZASLUJMSLYOO-UHFFFAOYSA-N 2-bromo-5-(trifluoromethyl)-8-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=C(C=C1)C1=CC=C(N2N=C(Br)N=C12)C(F)(F)F TWZASLUJMSLYOO-UHFFFAOYSA-N 0.000 description 1
- UOTQEEULPKCXDV-UHFFFAOYSA-N 2-bromo-6-(trifluoromethyl)-8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(F)C(F)=C(C=C1)C1=CC(=CN2N=C(Br)N=C12)C(F)(F)F UOTQEEULPKCXDV-UHFFFAOYSA-N 0.000 description 1
- ZOMHQFYGIHWHOM-UHFFFAOYSA-N 2-bromo-8-(2-chloro-4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=CC(Cl)=C(C=C1)C1CCCN2N=C(Br)N=C12 ZOMHQFYGIHWHOM-UHFFFAOYSA-N 0.000 description 1
- DSLBIFFCMLIYSS-UHFFFAOYSA-N 2-bromo-8-(3,4,5-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=CC(=CC(F)=C1F)C1=CC=CN2N=C(Br)N=C12 DSLBIFFCMLIYSS-UHFFFAOYSA-N 0.000 description 1
- GJDLUXLTFKUAMT-UHFFFAOYSA-N 2-bromo-8-(4-fluoro-2-methylphenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=C(C=CC(F)=C1)C1=CC=CN2N=C(Br)N=C12 GJDLUXLTFKUAMT-UHFFFAOYSA-N 0.000 description 1
- GVVNYNDVSVLUFR-UHFFFAOYSA-N 2-bromo-8-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 GVVNYNDVSVLUFR-UHFFFAOYSA-N 0.000 description 1
- QVHGHGCKJKCAFV-UHFFFAOYSA-N 2-bromo-8-[2-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)OC1=C(C=CC=C1)C1=CC=CN2N=C(Br)N=C12 QVHGHGCKJKCAFV-UHFFFAOYSA-N 0.000 description 1
- IZQGQOATGYFJJT-UHFFFAOYSA-N 2-bromo-8-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=C(C=CC=C1)C1=CC=CN2N=C(Br)N=C12 IZQGQOATGYFJJT-UHFFFAOYSA-N 0.000 description 1
- ANSGIOBYHRHNGD-UHFFFAOYSA-N 2-bromo-8-[2-methoxy-4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound COC1=C(C=CC(=C1)C(F)(F)F)C1=CC=CN2N=C(Br)N=C12 ANSGIOBYHRHNGD-UHFFFAOYSA-N 0.000 description 1
- GDASSJCXBNBZPX-UHFFFAOYSA-N 2-bromo-8-[3-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)OC1=CC=CC(=C1)C1=CC=CN2N=C(Br)N=C12 GDASSJCXBNBZPX-UHFFFAOYSA-N 0.000 description 1
- SOFWAYKYOLNRKO-UHFFFAOYSA-N 2-bromo-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=CC(=C1)C1=CC=CN2N=C(Br)N=C12 SOFWAYKYOLNRKO-UHFFFAOYSA-N 0.000 description 1
- BGZFRHUPNPUGRH-UHFFFAOYSA-N 2-bromo-8-[4-(1,1,2,2,2-pentafluoroethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C(F)(F)C1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 BGZFRHUPNPUGRH-UHFFFAOYSA-N 0.000 description 1
- KPTAEKTYEJDVNU-UHFFFAOYSA-N 2-bromo-8-[4-(2,2,2-trifluoroethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)COC1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 KPTAEKTYEJDVNU-UHFFFAOYSA-N 0.000 description 1
- GTSQACAPOUQEOS-UHFFFAOYSA-N 2-bromo-8-[4-(difluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)OC1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 GTSQACAPOUQEOS-UHFFFAOYSA-N 0.000 description 1
- QBARXRFTHAPXTE-UHFFFAOYSA-N 2-bromo-8-[4-(difluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)C1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 QBARXRFTHAPXTE-UHFFFAOYSA-N 0.000 description 1
- JZWNROAFCAHZIR-UHFFFAOYSA-N 2-bromo-8-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)OC1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 JZWNROAFCAHZIR-UHFFFAOYSA-N 0.000 description 1
- XGHHQZISRFMONR-UHFFFAOYSA-N 2-bromo-8-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 XGHHQZISRFMONR-UHFFFAOYSA-N 0.000 description 1
- BSOVAWQWIYEOAI-UHFFFAOYSA-N 2-bromo-8-[4-(trifluoromethylsulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)SC1=CC=C(C=C1)C1=CC=CN2N=C(Br)N=C12 BSOVAWQWIYEOAI-UHFFFAOYSA-N 0.000 description 1
- XWRFSNKLEIPFNN-UHFFFAOYSA-N 2-bromo-8-[4-fluoro-3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(C=C(C=C1)C1=CC=CN2N=C(Br)N=C12)C(F)(F)F XWRFSNKLEIPFNN-UHFFFAOYSA-N 0.000 description 1
- JWEVNWVMNYNRRL-UHFFFAOYSA-N 2-bromo-8-[5-fluoro-2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=CC(C2=CC=CN3N=C(Br)N=C23)=C(C=C1)C(F)(F)F JWEVNWVMNYNRRL-UHFFFAOYSA-N 0.000 description 1
- KLDLRDSRCMJKGM-UHFFFAOYSA-N 3-[chloro-(2-oxo-1,3-oxazolidin-3-yl)phosphoryl]-1,3-oxazolidin-2-one Chemical compound C1COC(=O)N1P(=O)(Cl)N1CCOC1=O KLDLRDSRCMJKGM-UHFFFAOYSA-N 0.000 description 1
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 1
- FMUVLOLSARCVAV-UHFFFAOYSA-N 5-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound FC1=C(C=CC(=C1F)F)C1=CC=CC=2N1N=C(N2)N FMUVLOLSARCVAV-UHFFFAOYSA-N 0.000 description 1
- DLILBKMOUOQUPL-UHFFFAOYSA-N 5-(trifluoromethyl)-8-(2,3,4-trifluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(CCC(C2=N1)C1=C(F)C(F)=C(F)C=C1)C(F)(F)F DLILBKMOUOQUPL-UHFFFAOYSA-N 0.000 description 1
- RSJOKYXACFWRKL-UHFFFAOYSA-N 5-(trifluoromethyl)-8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C(=N1)C(=CC=C2C(F)(F)F)C1=C(F)C(F)=C(F)C=C1 RSJOKYXACFWRKL-UHFFFAOYSA-N 0.000 description 1
- FTUDKTJSTAVOAM-UHFFFAOYSA-N 5-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound N12N=C(N)N=C2C=CC=C1C1=CC=CC=C1C(F)(F)F FTUDKTJSTAVOAM-UHFFFAOYSA-N 0.000 description 1
- HWINPDVUYUWFQI-UHFFFAOYSA-N 5-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound N12N=C(N)N=C2C=CC=C1C1=CC=CC(C(F)(F)F)=C1 HWINPDVUYUWFQI-UHFFFAOYSA-N 0.000 description 1
- KJLKRLDWQPENMK-UHFFFAOYSA-N 5-iodo-3-methyl-1,2-oxazole Chemical compound CC=1C=C(I)ON=1 KJLKRLDWQPENMK-UHFFFAOYSA-N 0.000 description 1
- BKAZKAKFTYEOIA-UHFFFAOYSA-N 5-iodo-3-methyl-1,2-thiazole Chemical compound CC=1C=C(I)SN=1 BKAZKAKFTYEOIA-UHFFFAOYSA-N 0.000 description 1
- NXJLKIGSDACJKC-UHFFFAOYSA-N 8-(1,3-benzodioxol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1=C2OCOC2=CC(C=2C3=NC(=NN3C=CC=2)N)=C1 NXJLKIGSDACJKC-UHFFFAOYSA-N 0.000 description 1
- RUAWBZMJJSKAMK-UHFFFAOYSA-N 8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC1=C(C=CC(=C1F)F)C=1C=2N(C=CC1)N=CN2 RUAWBZMJJSKAMK-UHFFFAOYSA-N 0.000 description 1
- FPWXIWYZCZSKCY-UHFFFAOYSA-N 8-(2-chloro-4-fluorophenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound ClC1=C(C=CC(=C1)F)C1C=2N(CCC1)N=C(N=2)N FPWXIWYZCZSKCY-UHFFFAOYSA-N 0.000 description 1
- STPRHJDMJIRMLU-UHFFFAOYSA-N 8-(4-fluoro-2-methylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound CC1=CC(F)=CC=C1C1=CC=CN2C1=NC(N)=N2 STPRHJDMJIRMLU-UHFFFAOYSA-N 0.000 description 1
- XPBCUDYCKQGNLV-UHFFFAOYSA-N 8-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C1=CC(OC)=CC=C1C1=CC=CN2C1=NC(N)=N2 XPBCUDYCKQGNLV-UHFFFAOYSA-N 0.000 description 1
- LWVCFJWIHKYPHU-UHFFFAOYSA-N 8-[(8-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)amino]-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound BrC=1C=2N(C=CC=1)N=C(N=2)NC1C2CN(CC1CC2)C(=O)O LWVCFJWIHKYPHU-UHFFFAOYSA-N 0.000 description 1
- PSMSSYFVWFZCFO-UHFFFAOYSA-N 8-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C=1C=CN2N=C(N)N=C2C=1C1=CC=CC=C1C(F)(F)F PSMSSYFVWFZCFO-UHFFFAOYSA-N 0.000 description 1
- DGOLJPJOINJFHJ-UHFFFAOYSA-N 8-[2-fluoro-4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=C(F)C=C(C=C1)C(F)(F)F DGOLJPJOINJFHJ-UHFFFAOYSA-N 0.000 description 1
- YWALYOMCGQZNCV-UHFFFAOYSA-N 8-[3,5-bis(trifluoromethyl)phenyl]-2-bromo-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC(=CC(=C1)C1CCCN2N=C(Br)N=C12)C(F)(F)F YWALYOMCGQZNCV-UHFFFAOYSA-N 0.000 description 1
- QWEGNUKGLFMDFS-UHFFFAOYSA-N 8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C=1C=CN2N=C(N)N=C2C=1C1=CC=CC(C(F)(F)F)=C1 QWEGNUKGLFMDFS-UHFFFAOYSA-N 0.000 description 1
- YOGGRZMXQUTXQT-UHFFFAOYSA-N 8-[3-fluoro-5-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC(F)=CC(=C1)C(F)(F)F YOGGRZMXQUTXQT-UHFFFAOYSA-N 0.000 description 1
- KSEZBVTYYWYPHU-UHFFFAOYSA-N 8-[4-(1,1,2,2,2-pentafluoroethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC=C(C=C1)C(F)(F)C(F)(F)F KSEZBVTYYWYPHU-UHFFFAOYSA-N 0.000 description 1
- IXXXZKAKULPJHA-UHFFFAOYSA-N 8-[4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound C=1C=CN2N=C(N)N=C2C=1C1=CC=C(C(F)(F)F)C=C1 IXXXZKAKULPJHA-UHFFFAOYSA-N 0.000 description 1
- RVFQYRAKNFOEMN-UHFFFAOYSA-N 8-[4-fluoro-3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=CC(=C(F)C=C1)C(F)(F)F RVFQYRAKNFOEMN-UHFFFAOYSA-N 0.000 description 1
- WGQBRKQLHWSCCO-UHFFFAOYSA-N 8-[5-fluoro-2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound NC1=NN2C=CC=C(C2=N1)C1=C(C=CC(F)=C1)C(F)(F)F WGQBRKQLHWSCCO-UHFFFAOYSA-N 0.000 description 1
- QAQCFIUFMKBYQH-UHFFFAOYSA-N 8-[[5-(trifluoromethyl)-8-[2-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(C1=CC=C(C=2N1N=C(N=2)NC1C2CN(CC1CC2)C(=O)O)C1=C(C=CC=C1)C(F)(F)F)(F)F QAQCFIUFMKBYQH-UHFFFAOYSA-N 0.000 description 1
- GFPGKUKCZGACPM-UHFFFAOYSA-N 8-[[5-(trifluoromethyl)-8-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(C1=CC=C(C=2N1N=C(N=2)NC1C2CN(CC1CC2)C(=O)O)C1=CC(=CC=C1)C(F)(F)F)(F)F GFPGKUKCZGACPM-UHFFFAOYSA-N 0.000 description 1
- GUXKKLUDQOPYEA-UHFFFAOYSA-N 8-[[8-[2-fluoro-4-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC1=C(C=CC(=C1)C(F)(F)F)C=1C=2N(C=CC=1)N=C(N=2)NC1C2CN(CC1CC2)C(=O)O GUXKKLUDQOPYEA-UHFFFAOYSA-N 0.000 description 1
- MLNPJZJZWMWKTJ-UHFFFAOYSA-N 8-[[8-[4-fluoro-3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]amino]-3-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC1=C(C=C(C=C1)C=1C=2N(C=CC=1)N=C(N=2)NC1C2CN(CC1CC2)C(=O)O)C(F)(F)F MLNPJZJZWMWKTJ-UHFFFAOYSA-N 0.000 description 1
- KSAXUJOSDAELBS-UHFFFAOYSA-N 8-bromo-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine Chemical compound BrC1=CC(C(F)(F)F)=CN2N=C(N)N=C21 KSAXUJOSDAELBS-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Natural products CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 238000006418 Brown reaction Methods 0.000 description 1
- INPMNQMGOCYYSG-UHFFFAOYSA-N C1CC(C2=NC(=NN2C1)NC3C4CCC3CN(C4)C(=O)O)C5=C(C(=C(C=C5)F)F)F Chemical compound C1CC(C2=NC(=NN2C1)NC3C4CCC3CN(C4)C(=O)O)C5=C(C(=C(C=C5)F)F)F INPMNQMGOCYYSG-UHFFFAOYSA-N 0.000 description 1
- UNEODJWICRSLNE-UHFFFAOYSA-N C1CC2CN(CC1C2NC3=NN4C(CCC(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O Chemical compound C1CC2CN(CC1C2NC3=NN4C(CCC(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O UNEODJWICRSLNE-UHFFFAOYSA-N 0.000 description 1
- WKDJSKCCUPWJOF-UHFFFAOYSA-N C1CC2CN(CC1C2NC3=NN4C=C(C=C(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O Chemical compound C1CC2CN(CC1C2NC3=NN4C=C(C=C(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O WKDJSKCCUPWJOF-UHFFFAOYSA-N 0.000 description 1
- VUSUQVPESVZSAG-UHFFFAOYSA-N C1CC2CN(CC1C2NC3=NN4C=CC=C(C4=N3)C5=C(C=C(C=C5)CF)F)C(=O)O Chemical compound C1CC2CN(CC1C2NC3=NN4C=CC=C(C4=N3)C5=C(C=C(C=C5)CF)F)C(=O)O VUSUQVPESVZSAG-UHFFFAOYSA-N 0.000 description 1
- BLOIMKDKUSDDRY-UHFFFAOYSA-N C1CC2CN(CC1C2NC3=NN4C=CC=C(C4=N3)C5=CC=C(C=C5)OC(F)(F)F)C(=O)O Chemical compound C1CC2CN(CC1C2NC3=NN4C=CC=C(C4=N3)C5=CC=C(C=C5)OC(F)(F)F)C(=O)O BLOIMKDKUSDDRY-UHFFFAOYSA-N 0.000 description 1
- NOCZLEQWIDBXOL-UHFFFAOYSA-N C1CC2CN(CC1C2NC3=NN4CC(CC(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O Chemical compound C1CC2CN(CC1C2NC3=NN4CC(CC(C4=N3)C5=C(C(=C(C=C5)F)F)F)C(F)(F)F)C(=O)O NOCZLEQWIDBXOL-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ICMAFTSLXCXHRK-UHFFFAOYSA-N Ethyl pentanoate Chemical compound CCCCC(=O)OCC ICMAFTSLXCXHRK-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 101000650817 Homo sapiens Semaphorin-4D Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- RKOTXQYWCBGZLP-UHFFFAOYSA-N N-[(2,4-difluorophenyl)methyl]-2-ethyl-9-hydroxy-3-methoxy-1,8-dioxospiro[3H-pyrido[1,2-a]pyrazine-4,3'-oxolane]-7-carboxamide Chemical compound CCN1C(OC)C2(CCOC2)N2C=C(C(=O)NCC3=C(F)C=C(F)C=C3)C(=O)C(O)=C2C1=O RKOTXQYWCBGZLP-UHFFFAOYSA-N 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 238000000297 Sandmeyer reaction Methods 0.000 description 1
- 102100027744 Semaphorin-4D Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 206010044688 Trisomy 21 Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- DACWQSNZECJJGG-UHFFFAOYSA-N [1,2,4]triazolo[1,5-a]pyridine Chemical group C1=CC=CN2N=CN=C21 DACWQSNZECJJGG-UHFFFAOYSA-N 0.000 description 1
- SSFSVKVWAURAAM-UHFFFAOYSA-N [2-fluoro-4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1F SSFSVKVWAURAAM-UHFFFAOYSA-N 0.000 description 1
- UCNRYDKUBYQIOW-UHFFFAOYSA-N [2-methoxy-4-(trifluoromethyl)phenyl]boronic acid Chemical compound COC1=CC(C(F)(F)F)=CC=C1B(O)O UCNRYDKUBYQIOW-UHFFFAOYSA-N 0.000 description 1
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 1
- WEMCWZGCSRGJGW-UHFFFAOYSA-N [3-fluoro-5-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(F)=CC(C(F)(F)F)=C1 WEMCWZGCSRGJGW-UHFFFAOYSA-N 0.000 description 1
- DWRAMTYYMNLVBD-UHFFFAOYSA-N [4-(2,2,2-trifluoroethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OCC(F)(F)F)C=C1 DWRAMTYYMNLVBD-UHFFFAOYSA-N 0.000 description 1
- HUOFUOCSQCYFPW-UHFFFAOYSA-N [4-(trifluoromethoxy)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(OC(F)(F)F)C=C1 HUOFUOCSQCYFPW-UHFFFAOYSA-N 0.000 description 1
- GUJYFCBXDUPORN-UHFFFAOYSA-N [4-fluoro-3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(F)C(C(F)(F)F)=C1 GUJYFCBXDUPORN-UHFFFAOYSA-N 0.000 description 1
- LBDUHXAQWUKBEB-UHFFFAOYSA-N [5-fluoro-2-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(F)=CC=C1C(F)(F)F LBDUHXAQWUKBEB-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 108010064397 amyloid beta-protein (1-40) Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 101150089041 aph-1 gene Proteins 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ACONPURZGJUVLW-UHFFFAOYSA-N chloroform;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl ACONPURZGJUVLW-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 150000002013 dioxins Chemical class 0.000 description 1
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 1
- BOBUBHOXRCYKLI-UHFFFAOYSA-N ditert-butyl(cyclopenta-2,4-dien-1-yl)phosphane;iron(2+);(2,3,4,5-tetraphenylcyclopenta-1,4-dien-1-yl)benzene Chemical compound [Fe+2].CC(C)(C)P(C(C)(C)C)C1=CC=C[CH-]1.C1=CC=CC=C1C1=C(C=2C=CC=CC=2)[C-](C=2C=CC=CC=2)C(C=2C=CC=CC=2)=C1C1=CC=CC=C1 BOBUBHOXRCYKLI-UHFFFAOYSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- AIGRXSNSLVJMEA-FQEVSTJZSA-N ethoxy-(4-nitrophenoxy)-phenyl-sulfanylidene-$l^{5}-phosphane Chemical compound O([P@@](=S)(OCC)C=1C=CC=CC=1)C1=CC=C([N+]([O-])=O)C=C1 AIGRXSNSLVJMEA-FQEVSTJZSA-N 0.000 description 1
- OVTXWZSJDIFYMP-UHFFFAOYSA-N ethyl 2-[3,5-bis(trifluoromethyl)phenyl]-5-(oxan-2-yloxy)pentanoate Chemical compound FC(C=1C=C(C=C(C=1)C(F)(F)F)C(C(=O)OCC)CCCOC1OCCCC1)(F)F OVTXWZSJDIFYMP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- GDQYFKGLAUOXST-UHFFFAOYSA-N indolizin-2-amine Chemical compound C1=CC=CN2C=C(N)C=C21 GDQYFKGLAUOXST-UHFFFAOYSA-N 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002605 large molecules Chemical group 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DFTYYBRLWCAUHP-UHFFFAOYSA-N methyl 2-(2-chloro-4-fluorophenyl)acetate Chemical compound COC(=O)CC1=CC=C(F)C=C1Cl DFTYYBRLWCAUHP-UHFFFAOYSA-N 0.000 description 1
- BXNYZIJXGIVTJL-UHFFFAOYSA-N methyl 5-chloro-2-(2-chloro-4-fluorophenyl)pentanoate Chemical compound COC(C(CCCCl)C1=C(C=C(C=C1)F)Cl)=O BXNYZIJXGIVTJL-UHFFFAOYSA-N 0.000 description 1
- SDDKIZNHOCEXTF-UHFFFAOYSA-N methyl carbamimidothioate Chemical compound CSC(N)=N SDDKIZNHOCEXTF-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNBDRPTVWVGKBR-UHFFFAOYSA-N n-pentanoic acid methyl ester Natural products CCCCC(=O)OC HNBDRPTVWVGKBR-UHFFFAOYSA-N 0.000 description 1
- 210000002682 neurofibrillary tangle Anatomy 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 102000046701 nicastrin Human genes 0.000 description 1
- 108700022821 nicastrin Proteins 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- NOGORYGYLODPPL-UHFFFAOYSA-N o-methyl methanethioate Chemical compound COC=S NOGORYGYLODPPL-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- DKACXUFSLUYRFU-UHFFFAOYSA-N tert-butyl n-aminocarbamate Chemical compound CC(C)(C)OC(=O)NN DKACXUFSLUYRFU-UHFFFAOYSA-N 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- LENLQGBLVGGAMF-UHFFFAOYSA-N tributyl([1,2,4]triazolo[1,5-a]pyridin-6-yl)stannane Chemical compound C1=C([Sn](CCCC)(CCCC)CCCC)C=CC2=NC=NN21 LENLQGBLVGGAMF-UHFFFAOYSA-N 0.000 description 1
- 125000004360 trifluorophenyl group Chemical group 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15184480 | 2015-09-09 | ||
| EP15184480.0 | 2015-09-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201718601A TW201718601A (zh) | 2017-06-01 |
| TWI716446B true TWI716446B (zh) | 2021-01-21 |
Family
ID=54072754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105129076A TWI716446B (zh) | 2015-09-09 | 2016-09-08 | 橋聯哌啶衍生物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10604517B2 (enExample) |
| EP (1) | EP3347363B1 (enExample) |
| JP (1) | JP6831372B2 (enExample) |
| CN (1) | CN107922437B (enExample) |
| AR (1) | AR105965A1 (enExample) |
| TW (1) | TWI716446B (enExample) |
| WO (1) | WO2017042114A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI753009B (zh) * | 2016-09-09 | 2022-01-21 | 瑞士商赫孚孟拉羅股份公司 | 2-(6-硝基吡啶-3-基)-9H-二吡啶并[2,3-b;3',4'-d]吡咯之製備方法 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6831372B2 (ja) | 2015-09-09 | 2021-02-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 架橋ピペリジン誘導体 |
| JP7012715B2 (ja) * | 2016-06-27 | 2022-01-28 | エフ．ホフマン－ラ ロシュ アーゲー | γ－セクレターゼモジュレーターとしてのトリアゾロピリジン |
| AR109829A1 (es) * | 2016-09-29 | 2019-01-30 | Hoffmann La Roche | Derivados de piperidina puenteados |
| JP6956175B2 (ja) | 2016-10-04 | 2021-11-02 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 二環式ヘテロアリール誘導体 |
| WO2018083050A1 (en) * | 2016-11-01 | 2018-05-11 | F. Hoffmann-La Roche Ag | Bicyclic heteroaryl derivatives |
| JP7248671B2 (ja) * | 2017-12-18 | 2023-03-29 | エフ． ホフマン－ラ ロシュ アーゲー | トリアゾロ－アゼピン誘導体 |
| EP3743428B1 (en) * | 2018-01-22 | 2022-01-19 | F. Hoffmann-La Roche AG | Triazolo-azepine derivatives |
| SG11202102137SA (en) | 2018-09-03 | 2021-04-29 | Hoffmann La Roche | Bicyclic heteroaryl derivatives |
| SI3894411T1 (sl) | 2018-12-13 | 2024-10-30 | F. Hoffmann - La Roche Ag | Derivati 7-fenoksi-N-(3-azabiciklo(3.2.1)oktan-8-il)-6,7-dihidro-5H- pirolo(1,2-b)(1,2,4)triazol-2-amina in sorodne spojine kot modulatorji gama-sekretaze za zdravljenje Alzheimerjeve bolezni |
| IL283994B2 (en) | 2018-12-27 | 2024-05-01 | Hoffmann La Roche | Process for preparing exo-tert-butyl N-(3-azabicyclo[3.2.1]octane-8-YL)carbamate |
| US20230086702A1 (en) | 2019-04-18 | 2023-03-23 | The Johns Hopkins University | Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a]pyridine derivatives and use thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011101304A2 (en) * | 2010-02-17 | 2011-08-25 | F. Hoffmann-La Roche Ag | Piperidine derivatives |
| WO2012116965A1 (en) * | 2011-03-02 | 2012-09-07 | F. Hoffmann-La Roche Ag | Bridged piperidine derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003068776A1 (en) * | 2002-02-15 | 2003-08-21 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| ES2428716T3 (es) * | 2008-02-22 | 2013-11-11 | F. Hoffmann-La Roche Ag | Moduladores de beta-amiloide |
| US8502193B2 (en) * | 2008-04-16 | 2013-08-06 | Lg Innotek Co., Ltd. | Light-emitting device and fabricating method thereof |
| WO2010052199A1 (en) * | 2008-11-10 | 2010-05-14 | F. Hoffmann-La Roche Ag | Heterocyclic gamma secretase modulators |
| TWI461425B (zh) * | 2009-02-19 | 2014-11-21 | Janssen Pharmaceuticals Inc | 作為伽瑪分泌酶調節劑之新穎經取代的苯并唑、苯并咪唑、唑并吡啶及咪唑并吡啶衍生物類 |
| ES2431619T3 (es) * | 2009-05-07 | 2013-11-27 | Janssen Pharmaceuticals, Inc. | Derivados de indazol y aza-indazol sustituidos como moduladores de gamma-secretasa |
| WO2010138901A1 (en) * | 2009-05-29 | 2010-12-02 | Biogen Idec Ma Inc | Carboxylic acid-containing compounds, derivatives thereof, and related methods of use |
| WO2011050309A2 (en) * | 2009-10-23 | 2011-04-28 | Appsware Wireless, Llc | System and device for consolidating sim, personal token, and associated applications |
| US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| EP2687528A1 (en) * | 2012-07-17 | 2014-01-22 | Ares Trading S.A. | Fused triazole derivatives as gamma secretase modulators |
| JP6831372B2 (ja) | 2015-09-09 | 2021-02-17 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 架橋ピペリジン誘導体 |
-
2016
- 2016-09-05 JP JP2018512604A patent/JP6831372B2/ja active Active
- 2016-09-05 WO PCT/EP2016/070800 patent/WO2017042114A1/en not_active Ceased
- 2016-09-05 EP EP16763491.4A patent/EP3347363B1/en active Active
- 2016-09-05 CN CN201680051165.9A patent/CN107922437B/zh active Active
- 2016-09-08 AR ARP160102743A patent/AR105965A1/es unknown
- 2016-09-08 TW TW105129076A patent/TWI716446B/zh not_active IP Right Cessation
-
2018
- 2018-03-06 US US15/913,087 patent/US10604517B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011101304A2 (en) * | 2010-02-17 | 2011-08-25 | F. Hoffmann-La Roche Ag | Piperidine derivatives |
| WO2012116965A1 (en) * | 2011-03-02 | 2012-09-07 | F. Hoffmann-La Roche Ag | Bridged piperidine derivatives |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI753009B (zh) * | 2016-09-09 | 2022-01-21 | 瑞士商赫孚孟拉羅股份公司 | 2-(6-硝基吡啶-3-基)-9H-二吡啶并[2,3-b;3',4'-d]吡咯之製備方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107922437B (zh) | 2021-12-10 |
| US10604517B2 (en) | 2020-03-31 |
| CN107922437A (zh) | 2018-04-17 |
| HK1251902A1 (zh) | 2019-04-26 |
| EP3347363B1 (en) | 2020-01-01 |
| AR105965A1 (es) | 2017-11-29 |
| JP2018526410A (ja) | 2018-09-13 |
| TW201718601A (zh) | 2017-06-01 |
| WO2017042114A1 (en) | 2017-03-16 |
| EP3347363A1 (en) | 2018-07-18 |
| US20180237432A1 (en) | 2018-08-23 |
| JP6831372B2 (ja) | 2021-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI716446B (zh) | 橋聯哌啶衍生物 | |
| TWI629278B (zh) | 橋聯哌啶衍生物 | |
| JP2022163087A (ja) | Ｓｍｙｄ阻害剤 | |
| TWI738879B (zh) | 橋聯哌啶衍生物 | |
| US11319314B2 (en) | Phenoxytriazoles | |
| JP7111704B2 (ja) | 二環式ヘテロアリール誘導体 | |
| EP2681214A1 (en) | Bridged piperidine derivatives | |
| EA030085B1 (ru) | 2-АМИНО-6-МЕТИЛ-4,4a,5,6-ТЕТРАГИДРОПИРАНО[3,4-d][1,3]ТИАЗИН-8a(8H)-ИЛ-1,3-ТИАЗОЛ-4-ИЛ АМИДЫ | |
| AU2019395774B2 (en) | 7-phenoxy-N-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of Alzheimer's disease | |
| WO2024246018A1 (en) | Trem2 agonists | |
| US10875854B2 (en) | Triazolopyridines | |
| TWI841592B (zh) | 雙環雜芳基衍生物 | |
| AU2012222426B2 (en) | Bridged piperidine derivatives | |
| NZ612525B2 (en) | Bridged piperidine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |